Skip to content
OpenCapital
Get started

Tyra Biosciences, Inc. TYRA Balance Sheet Statement

Income StatementBalance SheetCash FlowRatiosSegments
QuarterlyAnnualTTM
YoYQoQ
SimplifiedDetailed
TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
Cash and cash equivalents
$84.96M-15.7%$77.39M-15.9%$61.95M-40.4%$98.49M-1.0%$100.72M-60.4%
Total current assets
$394.61M+21.6%$265.45M-23.6%$281.22M-23.1%$302.16M-20.2%$324.57M-16.9%
Property and equipment, net
$1.22M-20.2%$1.31M-20.4%$1.35M-24.8%$1.41M-25.6%$1.52M-4.5%
Total assets
$412.04M+20.0%$282.61M-22.3%$301.85M-20.7%$321.5M-18.1%$343.48M-15.1%
Accounts payable
$3.64M+45.7%$1.18M+99.7%$1.99M+70.9%$2.25M+42.4%$2.5M-13.2%
Total current liabilities
$19.26M+35.2%$18.09M+24.0%$15.88M+28.3%$13.77M+32.6%$14.25M+63.4%
Total liabilities
$24.47M+22.7%$23.43M+14.8%$21.34M+16.6%$19.35M+17.9%$19.94M+34.2%
Common stock
$6K+20.0%$5K0.0%$5K0.0%$5K0.0%$5K0.0%
Retained earnings
-$410.56M-46.9%-$371.26M-47.7%-$337.42M-49.5%-$307.56M-52.5%-$279.46M-52.7%
Total stockholders' equity
$387.58M+19.8%$259.18M-24.5%$280.51M-22.6%$302.15M-19.7%$323.53M-17.0%
Total liabilities and stockholders' equity
$412.04M+20.0%$282.61M-22.3%$301.85M-20.7%$321.5M-18.1%$343.48M-15.1%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Tyra Biosciences, Inc.'s total assets?
Tyra Biosciences, Inc. (TYRA) holds $412.0M in total assets, up 20.0% year over year.
How much debt does Tyra Biosciences, Inc. have?
Tyra Biosciences, Inc. carries $5.7M in total debt against $387.6M of shareholders' equity, a debt-to-equity ratio of 0.01.
How much cash does Tyra Biosciences, Inc. have?
Tyra Biosciences, Inc. holds $85.0M in cash and equivalents.
Can Tyra Biosciences, Inc. cover its short-term obligations?
Its current ratio is 20.49 — current assets exceed current liabilities.
Where does Tyra Biosciences, Inc.'s balance sheet data come from?
Every line is extracted from Tyra Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.